Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



In silico investigation of possible Caffeine interactions with common Inflammation-related targets

Lincon Fernandes de Lima Neto,Ana Carolina C rnio Barruffini,Isaac Yves Lopes Mac do,Fabio Bahls Machado,Douglas Vieira Thomaz.




Abstract
Cited by 2 Articles

Caffeine (CA) is a methylxantine alkaloid widely used in anti-inflammatory drug associations due to its vasoconstricting properties. Although CA is acknowledged to interact with a plethora of macromolecules in human organism, there was to the best of our knowledge no survey regarding its possible interactions with common inflammation-related targets. Henceforth, this work was concerned in the investigation of CA possible interactions with cyclooxygenases 1 and 2 (COX1 and 2) as well as prostaglandin H2 synthase-1 and leukotriene A4 hydrolase through in silico approaches. CA molecule was studied as a ligand whereas the ligand-macromolecules docking models were created through AutoDock Vina tools. Results evidenced that COX-1 and COX-2 best scoring models did not render enough information to imply interaction, while prostaglandin H2 synthase-1 and leukotriene A4 hydrolase did exhibit interesting results suggesting thermodynamic feasibility for possible interactions

Key words: methylxantine; docking; cyclooxygenase; leukotriene; prostaglandin.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.